{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:49:15Z","timestamp":1768340955908,"version":"3.49.0"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ci\u00eanc. sa\u00fade coletiva"],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:p>O artigo visa discutir o processo de consolida\u00e7\u00e3o de uma pol\u00edtica p\u00fablica, no Brasil, voltada a uma doen\u00e7a rara - a osteog\u00eanese imperfeita, cujo tratamento passou a responsabilidade do SUS em 2001 atrav\u00e9s da Portaria GM\/MS2305\/2001. O processo de implementa\u00e7\u00e3o desta terapia vem sendo acompanhado de contradi\u00e7\u00f5es, sobretudo no que diz respeito \u00e0s decis\u00f5es terap\u00eauticas e ao fortalecimento da rede especializada na abordagem desta condi\u00e7\u00e3o, atitudes claramente percebidas tanto no processo de elabora\u00e7\u00e3o quanto no texto da nova Portaria 714\/2010.<\/jats:p>","DOI":"10.1590\/1413-81232014192.15582012","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T03:10:39Z","timestamp":1395717039000},"page":"475-480","source":"Crossref","is-referenced-by-count":9,"title":["Contradi\u00e7\u00f5es das pol\u00edticas p\u00fablicas voltadas para doen\u00e7as raras: o exemplo do Programa de Tratamento da Osteog\u00eanese Imperfeita no SUS"],"prefix":"10.1590","volume":"19","author":[{"given":"Maria Angelica de Faria Domingues de","family":"Lima","sequence":"first","affiliation":[{"name":"Fiocruz,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafne Dain Gandelman","family":"Horovitz","sequence":"additional","affiliation":[{"name":"Fiocruz"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"TM [Internet]","first-page":"1993","volume-title":"Osteogenesis Imperfecta","author":"Steiner RD","year":"2005"},{"key":"ref2","series-title":"O que \u00e9 OI? [p\u00e1gina na Internet]","year":"2012"},{"key":"ref3","series-title":"Centers of Reference for rare disease in Europe: State-of-the-art in 2006 and Recommendations of the Rare Disease Task Force. Report; 2006 Dez","year":"2006"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence DO","year":"1979","journal-title":"J Med Genet"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/S1413-78522011000500010","article-title":"Determinantes da marcha independente na osteog\u00eanese imperfeita","volume":"19","author":"Moreira CLM","year":"2010","journal-title":"Acta Ortop Bras"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmg.2009.10.007","article-title":"Classification of Osteogenesis Impefecta revisited","volume":"53","author":"Van Dijk FS","year":"2010","journal-title":"Eur J Med Genet"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00350961","article-title":"Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta","volume":"16","author":"Devogelaer JP","year":"1987","journal-title":"Skel Radiol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1651-2227.1998.tb01388.x","article-title":"Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta","volume":"87","author":"Astr\u00f6m E","year":"1998","journal-title":"Acta Paediatrica"},{"issue":"14","key":"ref9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux FH","year":"1998","journal-title":"N Engl J Med"},{"key":"ref10","series-title":"Portaria no 2305\/2001, de 19 de dezembro de 2001. Aprova o Protocolo de Indica\u00e7\u00e3o de Tratamento Cl\u00ednico da osteogenesis imperfecta com pamidronato diss\u00f3dico no \u00e2mbito do Sistema \u00danico de Sa\u00fade - SUS","year":"2001"},{"key":"ref11","series-title":"Aplica\u00e7\u00e3o cl\u00ednica da evid\u00eancia cient\u00edfica: o caso da osteog\u00eanese imperfeita e o tratamento medicamentoso com bifosfonatos [disserta\u00e7\u00e3o]","author":"Lima MAFD","year":"2010"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1590\/S1413-81232004000200013","article-title":"A pesquisa cl\u00ednica no Brasil","volume":"9","author":"Zago MA","year":"2004","journal-title":"Cien Saude Colet"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S1413-81232002000100002","article-title":"Sa\u00fade p\u00fablica no primeiro e terceiro mundos: desafios e perspectivas","volume":"7","author":"Salzano FM","year":"2002","journal-title":"Cien Saude Colet"},{"key":"ref14","series-title":"Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Consulta P\u00fablica n\u00b0 40, de 10 de novembro de 2010. Submete a consulta p\u00fablica o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas - Osteog\u00eanese Imperfeita","year":"2010"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1210\/jc.2004-2054","article-title":"Single-dose pharmacokinetics and tolerability of alendronate 35- and 70- milligram tablets in children and adolescents with Osteogenesis imperfecta type I","volume":"90","author":"Ward LM","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","series-title":"Portaria n\u00b0 714, de 17 de dezembro de 2010. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas - Osteog\u00eanese Imperfeita","year":"2010"},{"key":"ref17","series-title":"Portaria n\u00b0375, de 10 de novembro de 2009. Aprova o roteiro a ser utilizado na elabora\u00e7\u00e3o de Protocolos Cl\u00ednicos e Diretrizes Terap\u00eauticas no \u00e2mbito da Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade","year":"2009"},{"key":"ref18","series-title":"Clinical Epidemiology: a basic science for clinical medicine","author":"Sackett DL","year":"1992"},{"issue":"Supl. 13","key":"ref19","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1590\/S1413-81232010000900019","article-title":"Medicamentos de alto custo para doen\u00e7as raras no Brasil: o exemplo das doen\u00e7as lisossomicas","volume":"15","author":"Souza MV","year":"2010","journal-title":"Cien Saude Colet"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: From the laboratory to the clinic and back again","volume":"25","author":"Russel RGG","year":"1999","journal-title":"Bone"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jc.2005-2413","article-title":"Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation","volume":"91","author":"Rauch F","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","series-title":"Declara\u00e7\u00e3o pessoal ao autor","author":"Rauch F","year":"2008"},{"key":"ref23","series-title":"O SUS de A a Z. Garantindo a sa\u00fade nos munic\u00edpios","year":"2009"},{"key":"ref24","series-title":"Portaria n\u00b0 708, de 25 de outubro de 2011. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas - Doen\u00e7a de Gaucher","year":"2011"}],"container-title":["Ci\u00eancia &amp; Sa\u00fade Coletiva"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/csc\/v19n2\/1413-8123-csc-19-02-00475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:15:11Z","timestamp":1495523711000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1413-81232014000200475&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1413-81232014000200475"],"URL":"https:\/\/doi.org\/10.1590\/1413-81232014192.15582012","relation":{},"ISSN":["1413-8123"],"issn-type":[{"value":"1413-8123","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}